Table 1

- Timeline table.

DatesRelevant past medical history and interventions
6 months earlierIntermittent morning headaches with on/off nausea and vomiting over six months diagnosed as sinusitis in a private clinic
DateSummaries from initial and follow-up visitsDiagnostic testing (including dates)Interventions
23 Mar 2022Presented to emergency department with increasing early morning headaches with nausea and vomiting over last one month. Physical examination revealed decreased sensation in the left V2 maxillary branch of the trigeminal nerve. Also bilateral papilledema and optic disc pallor. Otherwise, intact power, other sensations, and no cerebellar signs.Eye ultrasound showed 10 mm optic sheath diameter Non-contrast brain computed tomography (CT) demonstrated active hydrocephalus and right lateral ventricular mass with associated calcificationDexamethasone 8 mg STAT then 4 mg q6hrs
24 Mar 2022Patient was admitted to pediatric intensive care unit (PICU) in stable conditionMRI revealed a heterogeneously enhancing well-defined right lateral intraventricular mass measuring 6×5.3×3.3 cm.Emergency right septostomy with insertion of external ventricular drain (EVD)
30 Mar 2022Patient intubated and ventilated after surgery. The preoperative symptoms markedly improved after tumor debulking, however, she developed three episodes of tonic-clonic seizures.Pathological diagnosis is subependymal giant cell astrocytoma Tumor genomic analysis showed pathogenic TSC2 mutation No clinical or radiological TSC stigmataRight frontal craniotomy and maximum safety resection of about 70% of the intraventricular tumor Levetiracetam 500 mg BID
12 Apr 2022Patient extubated successfully but found to have buccofascial apraxia and mild left sided weakness which improved a lot with PT and OT White blood cell count in the cerebrospinal fluid normalized after 2 weeks of broad spectrum antibioticsHigh white blood cell count in the cerebrospinal fluid without clinical signs of infectionBroad spectrum antibiotics for two weeks Removal of EVD and insertion of right occipital ventriculoperitoneal (VP) shunt
21 Apr 2022Discharged in good condition with no deficits  
19 May 2022Re-admitted for evacuation of post-operative subdural hemorrhage. Patient complained of headache and facial asymmetryMRI brain revealed stable residual tumor but there was a new left occipital subependymal 2.7 cm nodule with peripheral enhancementEverolimus (mTOR inhibitor) was administered at a starting dose of 4.5 mg/m2 per day then increased to 5 mg daily for two weeks, followed by a further increase to 7.5 mg daily
4 Sep 2022Outpatient visit The patient was asymptomatic and reported no adverse effectsFollow-up brain MRIs at three and six months intervals showed a reduction in the residual tumor size and occipital noduleContinue Everolimus treatement until it fails or the side effects become intolerable